CANCELLED: Things Look Fine, But We’re Doomed: Studying, and Stopping, Catastrophe

NOTICE

Seminar Cancellation

The Things Look Fine, But We’re Doomed: Studying, and Stopping, Catastrophe seminar has been CANCELLED. Rescheduling of this seminar is yet to be determined.


Thank you,
CISAC Events 

---------------------------------------------------------------------------------------------------------------------------------------------------------------

Livestream: This event will not be live-streamed or recorded.

About this Event: What is a catastrophe? Are catastrophes events or processes? How does imagining catastrophe motivate research and policymaking? Four CISAC scholars will tackle such questions in this wide-ranging conversation. Come prepared to discuss and argue!

Speakers' Biography:

Paul N. Edwards is Director of the Program on Science, Technology & Society and William J. Perry Fellow in International Security at Stanford University, as well as Professor of Information and History (Emeritus) at the University of Michigan. He writes and teaches about the history, politics, and culture of climate change science and information infrastructures.

Gabrielle Hecht is Frank Stanton Foundation Professor of Nuclear Security, as well as Professor of History and Professor (by courtesy) of Anthropology. She writes and teaches about toxic waste, radioactive contamination, social and global inequalities, and other foul things.

Megan J. Palmer is a Senior Research Scholar at the Center for International Security and Cooperation (CISAC) at Stanford. Her recent work explores how security is conceived and managed as biotechnology becomes increasingly accessible.

David A. Relman is the Thomas C. and Joan M. Merigan Professor in Medicine, and Microbiology & Immunology at Stanford University, Chief of Infectious Diseases at the VA Palo Alto Health Care System, and Senior Fellow at FSI. He served for four years as Science Co-Director at CISAC. Relman is interested in the emergence of risk at the advancing edge of the life sciences and associated technologies, and strategies for risk mitigation.